SCHEMBL20003253

SCHEMBL20003253

CCNCCCCCN(C)CC

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.50
CYP1A2 P05177 1/20 0.50
KDM1A O60341 5/20 0.46
MEN1 O00255 1/20 0.46
GLA P06280 1/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 2/20 0.44
KDM5A P29375 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
CHRM2 P08172 3/20 0.37
SAT1 P21673 2/20 0.35
PAOX Q6QHF9 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HRH4 Q9H3N8 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16789969 0.98 CYP2C19 (0.52) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL3608460 0.91 CYP2C19 (0.50) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL24764606 0.82 CYP2C19 (0.50) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL14044481 0.81 TSHR (0.55) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL15966144 0.81 TSHR (0.55) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL15966128 0.81 TSHR (0.55) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL15966125 0.81 TSHR (0.55) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL15966140 0.81 TSHR (0.55) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL14163249 0.81 CHRM2 (0.64) CYP2C19CYP1A2KDM1AMEN1GLA
SCHEMBL40907 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4166553-A1 ALKENYL PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Hongyun Biotech Co., Ltd. (CN) 2023-04-19 EP disclosed
WO-2018057834-A1 COMBINATORY TREATMENT STRATEGIES OF CANCER BASED ON RNA POLYMERASE I INHIBITION THE JOHNS HOPKINS UNIVERSITY (US) 2018-03-29 WO disclosed